OR WAIT null SECS
January 09, 2020
Privately owned global pharmaceutical company, Galen, has announced the completion of its acquisition of a boutique healthcare company, POA Pharma.
January 08, 2020
Roche will apply ProBioGen’s proprietary GlymaxX technology to boost the antibody-dependent cellular cytotoxicity activity of antibodies.
Catalent completes purchase of biologics fill-finish and oral solid dose facility in Anagni, Italy
PhoreMost, a biopharma company based in the United Kingdom, and Boehringer Ingelheim have entered into a multi-project drug discovery collaboration agreement, it was revealed.
January 06, 2020
The Ireland-based company can now offer complete elemental impurities testing services.
The new GMP conditioning product offering is designed to support clinical phase and commercialization stages of cell and gene therapy production.
Molecular taggants from Applied DNA Sciences and Colorcon’s Opadry coating target counterfeit and falsified medications.
January 03, 2020
The new site can manufacture oligonucleotide APIs at large scale.
Through the acquisition, Johnson & Johnson will gain access to Taris’ lead clinical-stage product, TAR-200.
Catalent’s planning service is designed to assist in evaluating needs for launching and maintaining clinical trials.